JPS5944313B2 - Manufacturing method of indazole derivatives - Google Patents
Manufacturing method of indazole derivativesInfo
- Publication number
- JPS5944313B2 JPS5944313B2 JP49135184A JP13518474A JPS5944313B2 JP S5944313 B2 JPS5944313 B2 JP S5944313B2 JP 49135184 A JP49135184 A JP 49135184A JP 13518474 A JP13518474 A JP 13518474A JP S5944313 B2 JPS5944313 B2 JP S5944313B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- phenyl
- melting point
- manufacturing
- aluminum hydride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は、一般式
X□ (1)
IR■ CH、N/ R”
\
R、
(式中Xは水素原子、ハロゲン原子又は低級アルキル基
、Rは低級アルキレン基、R、及びR2は同一でも異な
つてもよく、水素原子又は低級アルキル基を示し、R1
とR2は結合してフェニル基により置換されていてもよ
い異項環を形成してもよい)で表わされるインタゾール
誘導体の製法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention is based on the general formula R and R2 may be the same or different and represent a hydrogen atom or a lower alkyl group, and R1
and R2 may be combined to form a heterocyclic ring optionally substituted with a phenyl group).
本発明によれば式(I)の化合物は、一般式(式中X.
R.Rl及びR2は前記の意味を有する)で表わされる
化合物を還元することにより製造される。According to the invention, the compounds of formula (I) have the general formula (X.
R. R1 and R2 have the above meanings).
式1及び式の化合物において、R,とR2t)5結合し
て形成する異項環の残基としては、たとえばモルホリノ
基、ピペラジノ基等B5あげられ、これらの残基はフエ
ニル基により置換されていてもよい。In the compounds of formula 1 and formula, examples of the residue of the heterocyclic ring formed by bonding R and R2t)5 include B5 such as morpholino group and piperazino group, and these residues are substituted with a phenyl group. It's okay.
本発明に用いられる式の化合物は新規化合物であつて、
たとえば次ぎの反応により製造される特開昭51−59
862号公報参照)。式中X、R.R,およびR2は前
記の意味を有し、X″はハロゲン原子、R′は低級アル
キル基を示す。式の化合物としては、たとえば次ぎのも
のが用いられる。The compound of the formula used in the present invention is a new compound, and
For example, JP-A-51-59 produced by the following reaction
(See Publication No. 862). In the formula, X, R. R and R2 have the above-mentioned meanings, X'' represents a halogen atom, and R' represents a lower alkyl group. Examples of compounds of the formula include the following.
1−N−モノメチルカルバモイルエチル−3−フェニル
インタゾール、l−N−モノメチルカルバモイルエチル
−3−フエニル一5ークロロ−及び−5−メ千ルインダ
ゾール 1−N−フエニルピペラジノカルボニルエチル
一3−フエニル一5−メチルインタゾール、I−N,N
−ジメチルカルバモイルエチル−3−フエニル一5ーメ
チルインダゾリル、1−カルバモイルエチル−3−フエ
ニル一5−クロロインタゾール。1-N-monomethylcarbamoylethyl-3-phenylintazole, 1-N-monomethylcarbamoylethyl-3-phenyl-5-chloro- and -5-methylindazole 1-N-phenylpiperazinocarbonylethyl-3 -phenyl-5-methylintazole, I-N,N
-dimethylcarbamoylethyl-3-phenyl-5-methylindazolyl, 1-carbamoylethyl-3-phenyl-5-chlorointazole.
本発明を実施するに際し式の化合物の還元反応は、化合
物()を適宜な溶媒たとえばテトラヒドロフラン、エー
テル等に溶解し、これに通常の還元剤たとえばリチウム
アルミニウムハイドライド等を等モル量ないし過剰モル
量加え、室温ないしそれ以上の温度、好ましくは反応混
合物の還流温度で10〜60分間行なわれる。目的物質
(1)の単離、精製は常法により行なわれる。In carrying out the present invention, the reduction reaction of the compound of the formula is carried out by dissolving the compound () in an appropriate solvent such as tetrahydrofuran, ether, etc., and adding thereto an equimolar amount to an excess molar amount of a conventional reducing agent such as lithium aluminum hydride. The reaction is carried out for 10 to 60 minutes at room temperature or higher, preferably at the reflux temperature of the reaction mixture. Isolation and purification of the target substance (1) are carried out by conventional methods.
たとえば反応混合物に氷冷下に含水エーテルを滴加し、
さらにアルカリ水溶液たとえば水酸化ナトリウム水溶液
を加えて未反応の還元剤を分解させ、有機層を分取する
。有機層を水洗し、乾燥して減圧濃縮すると、目的物質
が得られる。目的物質は一般に油状物として得られ、こ
れを常法により適宜な無機酸塩又は有機酸塩、たとえば
塩酸塩、修酸塩、酒石酸塩、マロン酸塩等にすることが
できる。本発明により得られる式1の化合物は新規化合
物であつて、中枢抑制作用、抗うつ作用、抗炎症作用等
を有する医薬品として、またその合成用中間体としても
有用である。For example, adding aqueous ether dropwise to the reaction mixture under ice cooling,
Further, an aqueous alkali solution such as a sodium hydroxide solution is added to decompose the unreacted reducing agent, and the organic layer is separated. The organic layer is washed with water, dried and concentrated under reduced pressure to obtain the target substance. The target substance is generally obtained as an oil, which can be converted into an appropriate inorganic or organic acid salt, such as hydrochloride, oxalate, tartrate, malonate, etc., by a conventional method. The compound of formula 1 obtained by the present invention is a new compound and is useful as a pharmaceutical having central depressant action, antidepressant action, anti-inflammatory action, etc., and also as an intermediate for the synthesis thereof.
実施例 1
1−N−モノメチルカルバモイルエチル−3−フェニル
インタゾール(融点111〜112−C)5.0gを無
水テトラヒドロフラン40縞こ溶解し、リチウムアルミ
ニウムハイドライド1.5gを氷冷下に加え、攪拌下に
20分間加熱還流する。Example 1 5.0 g of 1-N-monomethylcarbamoylethyl-3-phenyl intazole (melting point 111-112-C) was dissolved in 40 strips of anhydrous tetrahydrofuran, 1.5 g of lithium aluminum hydride was added under ice cooling, and the mixture was stirred. Heat to reflux for 20 minutes.
次いで反応混合物に含水エーテル及び水酸化ナトリウム
水溶液を加え、有機層を分取し、有機層に10%塩酸を
加え、上澄液を分取する。上澄液に水酸化ナトリウム水
溶液を加えて塩基性にしたのちベンゼンで抽出し、有機
層を水洗し、芒硝で乾燥して減圧濃縮すると、1−N−
モノメチルアミノプロピル−3−フェニルインタゾール
1.29が油状物として得られる。これを常法により修
酸塩とする。この修酸塩をメタノールから再結晶すると
197〜198℃の融点(分解)を示す。実施例 2
1−N−モノメチルカルバモイルエチル−3−フエニル
一5−クロロインタゾール(融点123〜125一C)
5.09を、リチウムアルミニウムハイドライド1.5
f!を用いて実施例1と同様に処理すると、1−N−モ
ノメチルアミノプロピル−3−フエニル一5−クロロイ
ンタゾール修酸塩2.09が得られる。Next, aqueous ether and an aqueous sodium hydroxide solution are added to the reaction mixture, the organic layer is separated, 10% hydrochloric acid is added to the organic layer, and the supernatant liquid is separated. The supernatant liquid was made basic by adding an aqueous sodium hydroxide solution, and then extracted with benzene. The organic layer was washed with water, dried over sodium sulfate, and concentrated under reduced pressure to obtain 1-N-
1.29 g of monomethylaminopropyl-3-phenylintazole are obtained as an oil. This is made into oxalate by a conventional method. When this oxalate salt is recrystallized from methanol, it exhibits a melting point (decomposition) of 197-198°C. Example 2 1-N-monomethylcarbamoylethyl-3-phenyl-5-chlorointazole (melting point 123-1251C)
5.09, lithium aluminum hydride 1.5
f! When treated in the same manner as in Example 1, 2.09 g of 1-N-monomethylaminopropyl-3-phenyl-5-chlorointazole oxalate is obtained.
これをメタノールから再結晶すると203〜204℃の
融点(分解)を示す。実施例 31−N−モノメチルカ
ルバモイルエチル−3−フエニル一5−メチルインタゾ
ール(融点128〜13『C)5.09を、リチウムア
ルミニウムハイドライド1.59を用いて実施例1と同
様に処理すると、1−N−モノメチルアミノプロピル−
3ーフエニル一5−メチルインタゾール塩酸塩1.89
が得られる。When this is recrystallized from methanol, it exhibits a melting point (decomposition) of 203-204°C. Example 3 1-N-Monomethylcarbamoylethyl-3-phenyl-5-methylintazole (melting point 128-13'C) 5.09 was treated in the same manner as in Example 1 using lithium aluminum hydride 1.59. 1-N-monomethylaminopropyl-
3-phenyl-5-methylintazole hydrochloride 1.89
is obtained.
これをエタノール−エーテル混合溶媒から再結晶すると
148〜149゜Cの融点を示す。実施例 4
1−ヒドロキシカルボニルエチル−3−フエニル一5−
メチルインタゾールに、クロル炭素エチル及びN−フエ
ニルピペラジンを順次作用させて得られる1−N−フエ
ニルピペラジノカルボニルエチル一3−フエニル一5−
メチルインタゾール(油状物)4.09を、リチウムア
ルミニウムハイドライド1.29を用いて実施例1と同
様に処理すると、1−N−フエニルピペラジノプロピル
一3一フエニル一5−メチルインタゾール塩酸塩6.1
9が得られる。When this is recrystallized from a mixed solvent of ethanol and ether, it exhibits a melting point of 148-149°C. Example 4 1-Hydroxycarbonylethyl-3-phenyl-5-
1-N-phenylpiperazinocarbonylethyl-3-phenyl-5- obtained by sequentially reacting chlorocarbonethyl and N-phenylpiperazine with methyl intazole
When 4.09% of methyl intasol (oil) is treated with 1.29% of lithium aluminum hydride in the same manner as in Example 1, 1-N-phenylpiperazinopropyl-131 phenyl-5-methylintasol is obtained. Hydrochloride 6.1
9 is obtained.
これをエタノール−エーテル混合溶媒から再結晶すると
195〜200℃の融点を示す。実施例 5
1−N,N−ジメチルカルバモイルエチル−3−フエニ
ル一5−メチルインタゾール(融点99〜1000C)
5.0f!を、リチウムアルミニウムハイドライド1.
59を用いて実施例1と同様に処理すると、l−N,N
−ジメチルアミノプロピル−3−フエニル一5−メチル
インタゾール修酸塩1.99が得られる。When this is recrystallized from an ethanol-ether mixed solvent, it exhibits a melting point of 195-200°C. Example 5 1-N,N-dimethylcarbamoylethyl-3-phenyl-5-methylintazole (melting point 99-1000C)
5.0f! , lithium aluminum hydride 1.
59 and treated in the same manner as in Example 1, l-N,N
1.99 of -dimethylaminopropyl-3-phenyl-5-methylintasol oxalate are obtained.
これをエタノールから再結晶すると184〜185℃の
融点を示す。実施例 6
1−カルバモイルエチル−3−フエニル一5−クロロイ
ンタゾール(融点156〜1575C)5.09を、リ
チウムアルミニウムハイドライド1.59を用いて実施
例1と同様に処理すると、1−アミノプロピル−3−フ
エニル一5−クロロインタゾール塩酸塩2.09t)S
得られる。When this is recrystallized from ethanol, it shows a melting point of 184-185°C. Example 6 When 5.09 g of 1-carbamoylethyl-3-phenyl-5-chlorointasol (melting point 156-1575 C) was treated with 1.59 g of lithium aluminum hydride in the same manner as in Example 1, 1-aminopropyl -3-phenyl-5-chlorointasol hydrochloride 2.09t)S
can get.
Claims (1)
水素原子、ハロゲン原子又は低級アルキル基、Rは低級
アルキレン基、R_1及びR_2は同一でも異なつても
よく、水素原子又は低級アルキル基を示し、R_1とR
_2は結合してフェニル基により置換されていてもよい
異項環を形成してもよい)で表わされる化合物を還元す
ることを特徴とする、一般式▲数式、化学式、表等があ
ります▼( I )(式中X、R、R_1及びR_2は前
記の意味を有する)で表わされるインダゾール誘導体の
製法。[Claims] 1 General formula ▲ Numerical formula, chemical formula, table, etc. ▼ (III) (In the formula, X is a hydrogen atom, a halogen atom or a lower alkyl group, R is a lower alkylene group, R_1 and R_2 are the same or different may represent a hydrogen atom or a lower alkyl group, and R_1 and R
There are general formulas ▲ mathematical formulas, chemical formulas, tables, etc. ▼ ( I) A method for producing an indazole derivative represented by the formula (wherein X, R, R_1 and R_2 have the above-mentioned meanings).
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP49135184A JPS5944313B2 (en) | 1974-11-26 | 1974-11-26 | Manufacturing method of indazole derivatives |
US05/541,100 US3994890A (en) | 1974-01-31 | 1975-01-15 | 1-Aminoalkyl, 3-phenyl indazoles |
GB2247/75A GB1489280A (en) | 1974-01-31 | 1975-01-17 | Indazole derivatives |
FR7502955A FR2259601B1 (en) | 1974-01-31 | 1975-01-30 | |
DE2503815A DE2503815C2 (en) | 1974-01-31 | 1975-01-30 | Indazole derivatives, processes for their preparation and pharmaceuticals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP49135184A JPS5944313B2 (en) | 1974-11-26 | 1974-11-26 | Manufacturing method of indazole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5163172A JPS5163172A (en) | 1976-06-01 |
JPS5944313B2 true JPS5944313B2 (en) | 1984-10-29 |
Family
ID=15145788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP49135184A Expired JPS5944313B2 (en) | 1974-01-31 | 1974-11-26 | Manufacturing method of indazole derivatives |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5944313B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011073961A1 (en) | 2009-12-15 | 2011-06-23 | Natura Cosmeticos S.A | Process for obtaining a standardised extract of quercetin and 3-0-methylquercetin from flowers of macela (achyrocline satureioides), and cosmetic and pharmaceutical compositions comprising said extract |
US8927689B2 (en) | 2002-12-09 | 2015-01-06 | Ramot At Tel-Aviv University Ltd. | Peptide nanostructures and methods of generating and using the same |
US9394628B2 (en) | 2004-08-02 | 2016-07-19 | Ramot At Tel-Aviv University Ltd. | Method of forming a fiber made of peptide nanostructures |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE438401T1 (en) * | 2002-06-12 | 2009-08-15 | Chemocentryx Inc | 1-ARYL-4-SUBSTITUTED PIPERAZINE DERIVATIVES FOR USE AS CCR1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION AND IMMUNE DISEASES |
-
1974
- 1974-11-26 JP JP49135184A patent/JPS5944313B2/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8927689B2 (en) | 2002-12-09 | 2015-01-06 | Ramot At Tel-Aviv University Ltd. | Peptide nanostructures and methods of generating and using the same |
US9394628B2 (en) | 2004-08-02 | 2016-07-19 | Ramot At Tel-Aviv University Ltd. | Method of forming a fiber made of peptide nanostructures |
WO2011073961A1 (en) | 2009-12-15 | 2011-06-23 | Natura Cosmeticos S.A | Process for obtaining a standardised extract of quercetin and 3-0-methylquercetin from flowers of macela (achyrocline satureioides), and cosmetic and pharmaceutical compositions comprising said extract |
Also Published As
Publication number | Publication date |
---|---|
JPS5163172A (en) | 1976-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6056143B2 (en) | Amidine derivatives and their production method | |
MX2010014224A (en) | A process for the preparation of the apoptosis promoter abt-263. | |
US2971001A (en) | Quaternary salts of triphenylethanols, -ethylenes, and -ethanes | |
JPH02207083A (en) | Production of 2-nitroiminoimidazolidines | |
JPS596861B2 (en) | Method for producing 5-[(2-halogeno-1-hydroxy)alkyl[carbostyryl derivative] | |
JPS5944313B2 (en) | Manufacturing method of indazole derivatives | |
JPH01265045A (en) | Cyclopropane derivative | |
JPS5913510B2 (en) | Calbostyril Yudou Tainoseizohou | |
JPS597706B2 (en) | Calbostyril Yudou Tainoseizohou | |
JPS5936627B2 (en) | Production method of indazole derivatives | |
JPH023639A (en) | Production of 3, 3-diarylacrylamide | |
KR790000942B1 (en) | Process for preparing indazol derivatives | |
US3141893A (en) | 4-amino-coumarins | |
JPS595593B2 (en) | 3 Kanjiyousulfoxide Yuudoutaino Seizouhouhou | |
JPS596860B2 (en) | Method for producing 5-[(2-alkylamino-1-hydroxy)alkyl]carbostyryl derivative | |
KR100376280B1 (en) | Method for preparing cinnamaldehyde derivatives | |
JPS5944314B2 (en) | Manufacturing method of indazole derivatives | |
JPS596866B2 (en) | 5-((2-alkylamino-1-hydroxy)alkyl) carbostyril | |
JPS5936628B2 (en) | Production method of indazole derivatives | |
JPS6160673A (en) | Preparation of guanidinothiazole derivative | |
KR790001737B1 (en) | New process for the preparation of 4-amino-3,5-dihalogen-phenyl-ethanol amines | |
JPH023672A (en) | 2,6-diethylaniline derivative and production thereof | |
JPS597704B2 (en) | Calbostyril Yudou Tainoseizohou | |
JPS6019314B2 (en) | 2,3,6,7↓-tetrahydro↓-3↓-oxo↓-5H↓-pyridazino[3,4↓-b][1,4]oxazine derivative | |
KR790001740B1 (en) | Process for the preparation of benzanillde derivatives |